Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 43.15
-0.30 (-0.69%)
At close: Apr 17, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 3.25 billion as of April 20, 2026.
Market Cap
3.25B
Enterprise Value
2.45B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
43.15
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 3.25B, a decrease of -8.48%. That is a compound annual growth rate of -24.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.25B | -12.30% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celxpert Energy | 3.27B |
| Magnate Technology | 3.27B |
| Gongin Precision Ind. | 3.27B |
| Kura Sushi Asia | 3.26B |
| Gold Rain Enterprises | 3.25B |
| Long Time Technology | 3.23B |
| Mutual-Tek Industries | 3.23B |
| ReaLy Development & Construction | 3.23B |